Seer to Report First Quarter Financial Results on May 10, 2021
April 12, 2021 16:05 ET
|
Seer, Inc.
REDWOOD CITY, Calif., April 12, 2021 (GLOBE NEWSWIRE) -- Seer, Inc., (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will report...
Seer Reports Fourth Quarter and Full Year 2020 Financial Results and Fuels Commercial Progress in 2021 with New Collaborators and Partnerships
March 29, 2021 16:05 ET
|
Seer, Inc.
REDWOOD CITY, Calif., March 29, 2021 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today reported financial results...
Seer and SCIEX Sign Commercial Agreement to Offer End-to-End Unbiased Proteomics Solutions
March 29, 2021 16:05 ET
|
Seer, Inc.
REDWOOD CITY, Calif., March 29, 2021 (GLOBE NEWSWIRE) -- Seer (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, announced today that they have signed...
Seer to Report Fourth Quarter and Full Year 2020 Financial Results on March 29, 2021
March 01, 2021 08:05 ET
|
Seer, Inc.
REDWOOD CITY, Calif., March 01, 2021 (GLOBE NEWSWIRE) -- Seer, Inc., (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will report...
Seer to Present at the Cowen 41st Annual Healthcare Conference
February 24, 2021 16:05 ET
|
Seer, Inc.
REDWOOD CITY, Calif., Feb. 24, 2021 (GLOBE NEWSWIRE) -- Seer, Inc., (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will be...
Seer Appoints Deep Nishar and Mostafa Ronaghi, Ph.D. to its Board of Directors
February 17, 2021 08:00 ET
|
Seer, Inc.
REDWOOD CITY, Calif., Feb. 17, 2021 (GLOBE NEWSWIRE) -- Seer, Inc., (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it has appointed...
Seer Announces Closing of Public Offering of Common Stock
February 01, 2021 16:05 ET
|
Seer, Inc.
REDWOOD CITY, Calif. , Feb. 01, 2021 (GLOBE NEWSWIRE) -- Seer, Inc., a life sciences company commercializing a disruptive new platform for proteomics, today announced the closing of an underwritten...
Seer Announces Pricing of Upsized Public Offering of Common Stock
January 27, 2021 22:51 ET
|
Seer, Inc.
REDWOOD CITY, Calif., Jan. 27, 2021 (GLOBE NEWSWIRE) -- Seer, Inc., a life sciences company commercializing a disruptive new platform for proteomics, today announced the pricing of an underwritten...
Seer Announces Proposed Public Offering of Common Stock
January 25, 2021 16:35 ET
|
Seer, Inc.
REDWOOD CITY, Calif., Jan. 25, 2021 (GLOBE NEWSWIRE) -- Seer, Inc., a life sciences company commercializing a disruptive new platform for proteomics, today announced the commencement of a proposed...
Seer Signs Commercial Agreement to Provide Complete End-to-End Solution for Unbiased, Deep, Rapid and Large-Scale Proteomics
January 11, 2021 08:05 ET
|
Seer, Inc.
REDWOOD CITY, Calif., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Seer (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, announced today that it has signed a...